Skip to main content

Sullivan Louis W's Form 4 filing

United Therapeutics Corp (UTHR) · filed Dec 23, 2025

Accession no.
0001193522-25-000004
Filed
Dec 23, 2025
Trade date
Dec 22, 2025
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.05M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sullivan Louis WCIK 0001193522Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 22, 2025Common StockMOption exerciseAcquired+3,230$183.98+$594,255.43,230Indirect
Dec 22, 2025Common StockMOption exerciseAcquired+2,720$229.81+$625,083.25,950Indirect
Dec 22, 2025Common StockSSaleDisposed−1,087$511.22F2−$555,696.144,863Indirect
Dec 22, 2025Common StockSSaleDisposed−4,863$512.34F3−$2,491,509.420Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 22, 2025Common StockMOption exerciseDisposed−3,230$0.00$00Indirect
Dec 22, 2025Common StockMOption exerciseDisposed−2,720$0.00$01,840Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $510.64 to $511.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $511.67 to $512.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)